Cargando…
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
PURPOSE: To evaluate the effects of intravitreal bevacizumab (IVB) injection on chronic central serous chorioretinopathy (CSC). METHODS: In this prospective interventional case series, a total of 22 eyes of 22 patients, diagnosed with unresolved CSC for three months or longer, received 1.25 mg IVB i...
Autores principales: | Alishiri, Aliagha, Jadidi, Khosrow, Mosavi, Seyed Aliasghar, Torabi, Hamidreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896463/ https://www.ncbi.nlm.nih.gov/pubmed/31844791 http://dx.doi.org/10.1016/j.joco.2019.06.006 |
Ejemplares similares
-
Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy
por: Ünlü, Cihan, et al.
Publicado: (2016) -
The Effect of Intravitreal Bevacizumab on Central Serous Chorioretinopathy
por: Maleki, Alireza, et al.
Publicado: (2018) -
Ascorbic acid versus placebo in postoperative lid edema postphotorefractive keratectomy: A double-masked, randomized, prospective study
por: Alishiri, Aliagha, et al.
Publicado: (2019) -
The Effect of Intravitreal Bevacizumab in Patients with Acute Central Serous Chorioretinopathy
por: Lim, Ji Won, et al.
Publicado: (2010) -
Hemorrhagic Macular Infarction after Intravitreal Bevacizumab for Chronic Multifocal Central Serous Chorioretinopathy
por: Kelkar, Aditya, et al.
Publicado: (2014)